Efficacy of Kangliuwan for Recurrent Grade IV Glioma

Clinical trial NCT03949192 · UNKNOWN

Trial details

NCT number: NCT03949192
Sponsor: Xuanwu Hospital, Beijing
Status: UNKNOWN
Study type: OBSERVATIONAL

Glioma of Brain Recurrence

Start date: 2019-06-28
Primary completion: 2021-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.